166 related articles for article (PubMed ID: 19239915)
21. N-arachidonylethanolamide-induced increase in aqueous humor outflow facility.
Njie YF; Qiao Z; Xiao Z; Wang W; Song ZH
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4528-34. PubMed ID: 18539938
[TBL] [Abstract][Full Text] [Related]
22. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
23. A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
Kwiatkowska M; Parker LA; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jul; 174(2):254-9. PubMed ID: 14740147
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
27. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
28. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
29. The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat.
Rock EM; Limebeer CL; Mechoulam R; Piomelli D; Parker LA
Psychopharmacology (Berl); 2008 Feb; 196(3):389-95. PubMed ID: 17992520
[TBL] [Abstract][Full Text] [Related]
30. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
31. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
Darmani NA; McClanahan BA; Trinh C; Petrosino S; Valenti M; Di Marzo V
Neuropharmacology; 2005 Sep; 49(4):502-13. PubMed ID: 15921709
[TBL] [Abstract][Full Text] [Related]
33. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid modulation of male rat sexual behavior.
Gorzalka BB; Morrish AC; Hill MN
Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
[TBL] [Abstract][Full Text] [Related]
35. Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.
Thors L; Burston JJ; Alter BJ; McKinney MK; Cravatt BF; Ross RA; Pertwee RG; Gereau RW; Wiley JL; Fowler CJ
Br J Pharmacol; 2010 Jun; 160(3):549-60. PubMed ID: 20590565
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
[TBL] [Abstract][Full Text] [Related]
37. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
38. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
39. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
[TBL] [Abstract][Full Text] [Related]
40. Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
Umathe SN; Manna SS; Jain NS
Behav Brain Res; 2011 Sep; 223(1):125-34. PubMed ID: 21549765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
